Q1 2024 EPS Estimates for iTeos Therapeutics, Inc. Lifted by Analyst (NASDAQ:ITOS)
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities researchers at HC Wainwright boosted their Q1 2024 earnings per share (EPS) estimates for shares of iTeos Therapeutics in a report issued on Thursday, March 7th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings per share of ($1.22) for the quarter, […]
More Stories
Cell MedX (OTCMKTS:CMXC) Stock Price Down 6% – Should You Sell?
Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) fell 6% on Thursday . The company traded as low...
The European Equity Fund (NYSE:EEA) Trading Down 0.5% – What’s Next?
The European Equity Fund, Inc. (NYSE:EEA – Get Free Report)’s stock price traded down 0.5% on Thursday . The stock...
FIH group (LON:FIH) Trading Up 0.4% – What’s Next?
FIH group plc (LON:FIH – Get Free Report)’s share price traded up 0.4% on Thursday . The company traded as...
Jamieson Wellness (TSE:JWEL) Stock Price Down 0.8% – Should You Sell?
Jamieson Wellness Inc. (TSE:JWEL – Get Free Report) traded down 0.8% during trading on Thursday . The stock traded as...
Omega Therapeutics Chair Resigns from Board of Directors
On January 10, 2025, Omega Therapeutics, Inc. announced in an 8-K filing with the Securities and Exchange Commission that Christian...
CRH Completes Offering of Guaranteed Notes, CRH America Finance and SMW Finance DAC Issue SecuritiesCRH public limited company, listed on the New York Stock Exchange under the ticker CRH, recently completed a notable offering of U.S. Dollar Guarantee
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...